JacquesRobertLeclercMD

PubMed

• 28 citations
  Venous and arterial thromboembolism in severe sepsis.
  Robert Levine, Jacques R. LeClerc, Joan E. Bailey, Matthew J. Monberg, Samiha Sarwat> ;Thrombosis and Haemostasis. 2008 May 1
• 259 citations
  Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial Abciximab in Emergency Treatmen...
  Harold P. Adams, Mark B. Effron, James C. Torner, Antoni Dávalos, Judith Frayne, Philip Teal, Jacques R. Leclerc, Barry Oemar, Lakshmi Padgett, Elliot S. Barnathan, We...> ;Stroke. 2008 Jan 1
• 5 citations
  Treatment of heparin-induced thrombocytopenia with drotrecogin alfa (activated).
  George J. Rubeiz, Christopher M Marrone, Jacques R. LeClerc> ;Pharmacotherapy. 2006 Mar 1
• 75 citations
  Measuring Outcomes as a Function of Baseline Severity of Ischemic Stroke
  Harold P. Adams, Jacques R. Leclerc, Eric Bluhmki, William T. Clarke, Michael D. Hansen, Werner Hacke> ;Cerebrovascular Diseases. 2004 Aug 1
• 52 citations
  Platelet glycoprotein IIb/IIIa antagonists: Lessons learned from clinical trials and future directions
  Jacques R Leclerc> ;Critical Care Medicine. 2002 May 1
• 14 citations
  Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke.
  Julien Bogousslavsky, Jacques R. Leclerc> ;Neurology. 2001 Sep 1
• 7 citations
  A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep vein thrombosis.
  Susan R. Kahn, Lawrence Joseph, Steven A. Grover, Jacques R. Leclerc> ;Thrombosis Research. 2001 Apr 1
• 3 citations
  Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke.
  Julien Bogousslavsky, Jacques R. Leclerc> ;Cerebrovascular Diseases. 2001 Jan 1
• A single endotoxin injection in the rabbit causes prolonged blood vessel dysfunction and a procoagulant state.
  Leclerc J, Pu Q, Corseaux D, Haddad E, Decoene C, Bordet R, Six I, Jude B, Vallet B> ;Crit. Care Med.. 2000-11-01
• PLATELET GLYCOPROTEIN IIB/IIIA ANTAGONISTS IN ISCHEMIC CEREBROVASCULAR DISEASE
  Jacques R. Leclerc, Mary Ann Mascelli, Harlan F. Weisman> ;Coronary Artery Disease. 1999 Dec 1
• 52 citations
  Clinical prediction of deep vein thrombosis in patients with leg symptoms.
  Susan R. Kahn, Lawrence Joseph, Lucien Abenhaim, Jacques R. Leclerc> ;Thrombosis and Haemostasis. 1999 Mar 1
• 70 citations
  Outcome of asymptomatic patients with carotid disease
  Ariane Mackey, Michal Abrahamowicz, Y Langlois, Renaldo N. Battista, D Simard, F Bourque, Jacques R. Leclerc, Robert Côté> ;Neurology. 1997 Apr 1
• Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
  Gent M, Hirsh J, Ginsberg JS, Powers PJ, Levine MN, Geerts WH, Jay RM, Leclerc J, Neemeh JA, Turpie AG> ;Circulation. 1996-01-01
• 299 citations
  Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis
  Mark Levine, Jack Hirsh, Michael Gent, Alexander G.G. Turpie, Jeffrey I. Weitz, Jeffrey S. Ginsberg, William Geerts, Jacques R. Leclerc, Jean Neemeh, Peter Powers, Fra...> ;Thrombosis and Haemostasis. 1995 Aug 1
• 91 citations
  A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, ...
  Turpie Ag, Michael Gent, Robert Côté, Mark Levine, Jeffrey S. Ginsberg, Peter Powers, Jacques R. Leclerc, William Geerts, Richard M. Jay, Jean Neemeh> ;Annals of Internal Medicine. 1992 Sep 1
• 247 citations
  Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
  Mark Levine, Jack Hirsh, Michael Gent, Alexander G.G. Turpie, Jacques R. Leclerc, Peter Powers, Richard M. Jay, Jean Neemeh> ;Annals of Internal Medicine. 1991 Apr 1
• Prevention of deep vein thrombosis after major knee surgery--a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo.
  Leclerc, J. R., Geerts, W. H., Desjardins, L., Jobin, F., Laroche, F., Delorme, F., Haviernick, S., Atkinson, S., Bourgouin, J.> ;Thromb Haemost. 1992 Apr 2
• [Strategies for prevention of pulmonary embolism during at-risk surgeries and in the medical environment].
  Leclerc, J. R.> ;Rev Mal Respir. 1999 Nov
• Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia.
  Robitaille, D., Leclerc, J. R., Laberge, R., Sahab, P., Atkinson, S., Cartier, R.> ;J Thorac Cardiovasc Surg. 1992 Mar
• Join now to see all